» Articles » PMID: 31894548

Oxidative Stress, Frailty and Cardiovascular Diseases: Current Evidence

Overview
Date 2020 Jan 3
PMID 31894548
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this chapter is to review the results of recent studies analyzing the role of oxidative stress and systemic inflammation as potential contributors to frailty and CVD, and to explain a possible pathogenic relationship between the latter two conditions. Available evidence suggests that frail patients have elevated levels of oxidative stress biomarkers and proinflammatory cytokines, as well as with reduced concentrations of endogenous antioxidants. This implies that oxidative stress and systemic inflammation might play a role in the pathogenesis of frailty, but an underlying mechanism of this relationship is still mostly hypothetical. Oxidative stress and systemic inflammation are also involved in the pathogenesis of CVD. Cardiovascular conditions are established risk factor for frailty and in turn, presence of frailty constitutes an unfavorable prognostic factor in cardiac patients. Finally, some cardiovascular risk factors, such as lack of physical activity, smoking, obesity and inappropriate diet, are also involved in the etiology of oxidative stress, chronic inflammation and frailty. This complex interplay between intrinsic and extrinsic elements should be considered during holistic management of older persons with frailty and/or cardiovascular conditions.

Citing Articles

Reactive Oxygen Species: Role in Pathophysiology, and Mechanism of Endogenous and Dietary Antioxidants during Oxidative Stress.

Sikder M, Li X, Akumwami S, Labony S Chonnam Med J. 2025; 61(1):32-45.

PMID: 39958267 PMC: 11821989. DOI: 10.4068/cmj.2025.61.1.32.


Assessing Association Between Circulating Bilirubin Levels and the Risk of Frailty: An Observational and Mendelian Randomization Study.

Wu J, Xu J, Zou H, Ouyang Y, Li S, Wu L J Cachexia Sarcopenia Muscle. 2024; 16(1):1-11.

PMID: 39582374 PMC: 11670173. DOI: 10.1002/jcsm.13642.


Heart Failure With Preserved Ejection Fraction and Frailty: From Young to Superaged Coexisting HFpEF and Frailty.

Rakisheva A, Soloveva A, Shchendrygina A, Giverts I Int J Heart Fail. 2024; 6(3):93-106.

PMID: 39081641 PMC: 11284337. DOI: 10.36628/ijhf.2023.0064.


New insights into healthy ageing, inflammageing and frailty using metabolomics.

Abdullah G, Akpan A, Phelan M, Wright H Front Aging. 2024; 5:1426436.

PMID: 39044748 PMC: 11263002. DOI: 10.3389/fragi.2024.1426436.


Protective Effects of - on Cell Death Signals on the Bone Marrow-Derived Human Mesenchymal Stem Cells via Regulation of MKK7/JNK/c-Jun Signaling Pathway.

Yoon H, Cho S, Kim H, Lee J J Pharmacopuncture. 2024; 27(2):131-141.

PMID: 38948312 PMC: 11194519. DOI: 10.3831/KPI.2024.27.2.131.